Trial intelligence / Profile preview

RIME-IVF: Beta-blockers in Idiopathic Ventricular Fibrillation

NCT07405229Phase 4Recruiting

Start
May 2018
Primary completion
Dec 2032
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of carvedilol in ventricular fibrillation (VF). Started May 2018; status: recruiting.

02

Drugs

carvedilol
03

Conditions

ventricular fibrillation (VF)

Beyond the preview

Go deeper on NCT07405229.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07405229.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call